This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
After second attempt, Argos Therapeutics finalizes $46.3mm IPO on Nasdaq
26 Feb 2015
Cancer and infectious disease immunotherapy company Argos Therapeutics Inc. netted $46.3mm through an IPO of 6.2mm shares (including partial exercise of the overallotment) at $8, selling more shares than the 4.25mm it originally expected, when it filed in December 2013, but below its proposed $13-15 range. In Argos’ first attempt to go public in July 2011, it set terms at 5.25mm shares with a $13-15 price range, but withdrew the offering in March 2012 due to poor market conditions.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?